Fig. 3From: Effects of a new nutraceutical combination on cognitive function in hypertensive patientsVisual analogue scale (EQ-VAS) score at baseline and after 6 months in the active treated group. * p < 0.001 for treatment effect (active treatment vs. placebo), GLM analysisBack to article page